NCT05788614 Retroversion in Reverse Shoulder Arthroplasty
| NCT ID | NCT05788614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitario Reina Sofia de Cordoba |
| Condition | Shoulder Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2022-06-30 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2022-06-30 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare function in reverse shoulder arthroplasty (RSA) using two different degrees of humeral retroversion (RV). The main question it aims to answer is: • Does external rotation improves when using a higher retroversion? Participants will randomly receive a 0 degree or 30 degree RV for their RSA. They will be followed for two years and clinical outcomes will be recorded and analyzed.
Eligibility Criteria
Inclusion Criteria: * patients \> 60 years * primary rotator cuff arthropathy * implantation of reverse shoulder arthroplasty Exclusion Criteria: * previous surgeries in the shoulder * post-traumatic arthropathy
Contact & Investigator
Jose Carlos Minarro, Dr
PRINCIPAL INVESTIGATOR
Hospital Universitario Reina Sofía de Córdoba
Frequently Asked Questions
Who can join the NCT05788614 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Shoulder Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05788614 currently recruiting?
Yes, NCT05788614 is actively recruiting participants. Contact the research team at josecarlosdiaz10@gmail.com for enrollment information.
Where is the NCT05788614 trial being conducted?
This trial is being conducted at Córdoba, Spain.
Who is sponsoring the NCT05788614 clinical trial?
NCT05788614 is sponsored by Hospital Universitario Reina Sofia de Cordoba. The principal investigator is Jose Carlos Minarro, Dr at Hospital Universitario Reina Sofía de Córdoba. The trial plans to enroll 90 participants.